Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Yo_Mama_Been_Loggin

(107,112 posts)
Sun Apr 2, 2017, 09:01 PM Apr 2017

The governments struggle to hold opioid manufacturers accountable

To combat an escalating opioid epidemic, the Drug Enforcement Administration trained its sights in 2011 on Mallinckrodt Pharmaceuticals, one of the nation’s largest manufacturers of the highly addictive generic painkiller oxycodone.

It was the first time the DEA had targeted a manufacturer of opioids for alleged violations of laws designed to prevent diversion of legal narcotics to the black market. And it would become the largest prescription-drug case the agency has pursued.

Ultimately, the DEA and federal prosecutors would contend that the company ignored its responsibility to report suspicious orders as 500 million of its pills ended up in Florida between 2008 and 2012 — 66 percent of all oxycodone sold in the state. Government investigators alleged in internal documents that the company’s lack of due diligence could have resulted in nearly 44,000 federal violations and exposed it to $2.3 billion in fines, according to confidential government records and emails obtained by The Washington Post.

But six years later, after four investigations that spanned five states, the government has taken no legal action against Mallinckrodt. Instead, the company has reached a tentative settlement with federal prosecutors, according to sources familiar with the discussions. Under the proposal, which remains confidential, Mallinckrodt would agree to pay a $35 million fine and admit no wrongdoing.

https://www.washingtonpost.com/graphics/investigations/dea-mallinckrodt/?utm_term=.0f1b839f048a&wpisrc=al_alert-national&wpmk=1

5 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
The governments struggle to hold opioid manufacturers accountable (Original Post) Yo_Mama_Been_Loggin Apr 2017 OP
And Trump puts Christie in charge of this problem? IdiotsforPalin Apr 2017 #1
Ironic also these drugs are considered " white peoples drugs" kimbutgar Apr 2017 #2
And suddenly drug abuse is not a moral failing deserving of incarceration, but rather an Squinch Apr 2017 #3
Amazing, isn't it? dalton99a Apr 2017 #5
So Trump will use one type of addict to manage a program for other types of addicts... TheDebbieDee Apr 2017 #4

kimbutgar

(20,882 posts)
2. Ironic also these drugs are considered " white peoples drugs"
Sun Apr 2, 2017, 09:06 PM
Apr 2017

Reagan incarcerated a lot of crack users and but turned a blind eye to cocaine the rich white person drug. I knew rich white coke heads in 80's. it's a destructive drug like these opioids today.

Squinch

(50,774 posts)
3. And suddenly drug abuse is not a moral failing deserving of incarceration, but rather an
Sun Apr 2, 2017, 09:15 PM
Apr 2017

illness deserving of empathy.

Gosh. What a coincidence!

Latest Discussions»General Discussion»The governments struggle ...